ALDOB and hepatocellular carcinoma: In HCC, for example, low ALDOB expression is associated with more aggressive disease and poorer prognosis, whereas restoring ALDOB expression inhibits tumor invasiveness in part by upregulating the DNA demethylase TET1 186.